News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ranbaxy Laboratories (RANBAXY.BO)' Indian Facilities Under Scanner: Ghulam Nabi Azad


8/7/2013 6:57:36 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ranbaxy facilities in India are being reviewed after its US arm, Ranbaxy USA admitted to manufacturing certain drugs which didn’t follow the rules of ‘good manufacturing practices’ and were considered ‘adulterated’ under USFDA law, Health Minister Ghulam Nabi Azad said.The Minister was replying to a query in Rajya Sabha on steps taken by the government to ensure that ‘adulterated’ drugs are not sold in India after Ranbaxy USA Inc admitted in the US District Court of Maryland to manufacturing and distribution of certain drugs not in conformity with GMP. The Drugs Controller General of India has been ordered to review facilities of Ranbaxy in the country to ascertain the quality of drugs manufactured for domestic market, he said.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at PharmaBiz


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES